What is Immunitybio Inc?
, a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 6.40B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 2106,056 shares $1.1M | 0 |
| 3-6months | 6435,443 shares $3.9M | 0 |
| 6-9months | 3265,000 shares $2.8M | 0 |
| 9-12months | 5236,967 shares $1.6M | 0 |